Anxiety and Depression in Implanted Cardioverter-Defibrillator Recipients and Heart Failure: A Review

Heart Failure Clinics

Volumn 7, Issue 1, 2011, Pages 59-68

  Freedenberg, Vicki ^a   Thomas, Sue A ^b   Friedmann, Erika ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

Age; Gender; ICD; Implantable cardioverter defibrillator; Psychological distress; Shocks

Indexed keywords

AGE DISTRIBUTION; ANXIETY; COGNITIVE THERAPY; DEFIBRILLATOR; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; HEART FAILURE; HUMAN; PSYCHOEDUCATION; REVIEW; SECONDARY PREVENTION; SEX DIFFERENCE; SHOCK WAVE; SUDDEN DEATH;

ADAPTATION, PSYCHOLOGICAL; AGE FACTORS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; DEFIBRILLATORS, IMPLANTABLE; DEPRESSION; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 78649402711     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.08.008     Document Type: Review

References (63)

1. Glikson M., Friedman P.A. The implantable cardioverter defibrillator. Lancet 2001, 357(9262):1107-1117.
2. Moss A.J., Brown M., Cannon D.S., et al. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005, 10(Suppl 4):34-43.
3. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352(3):225-237.
4. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112(12):154-235.
5. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006, 48(5):e247-e346.
6. Sears S.F., Stutts L.A., Aranda J.M., et al. Managing congestive heart failure patient factors in the device era. Congest Heart Fail 2006, 12(6):335-340.
7. Sears S.F., Todaro J.F., Lewis T.S., et al. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999, 22(7):481-489.
8. DeJong J.M., Moser D.K., Chung M.L. Predictors of health status for heart failure patients. Prog Cardiovasc Nurs 2005, 20(4):155-162.
9. Faller H., Stork S., Schowalter M., et al. Depression and survival in chronic heart failure: does gender play a role?. Eur J Heart Fail 2007, 9(10):1018-1023.
10. Faris R., Purcell H., Henein M.Y., et al. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 2002, 4:541-551.
11. Friedmann E., Thomas S.A., Inguito P., et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol 2006, 17:65-72.
12. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161(15):1849-1856.
13. Jiang W., Kuchibhatla M., Cuffe M.S., et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004, 110(22):3452-3456.
14. Murberg T.A. Long-term effect of social relationships on mortality in patients with congestive heart failure. Int J Psychiatry Med 2004, 34(3):207-217.
15. Rumsfeld J.S., Haveranek E.P., Masoudi F., et al. Depressive symptoms and the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003, 42:1811-1817.
16. Sherwood A., Blumenthal J.A., Trivedi R., et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007, 167(4):367-373.
17. Westlake C., Dracup K., Fonarow G., et al. Depression in patients with heart failure. J Card Fail 2005, 11(1):30-35.
18. Friedmann E., Thomas S.A., Liu F., et al. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 2006, 152(5):940-948.
19. Haworth J.E., Moniz-Cook E., Clark A.L., et al. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005, 7(5):803-808.
20. Murberg T.A., Bru E., Aarsland T., et al. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med 1998, 28(3):273-291.
21. Gottlieb S.S., Khatta M., Friedmann E., et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004, 43(9):1542-1549.
22. Thomas S.A., Friedmann E., Kao C.W., et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006, 15(4):389-398.
23. DeMaso D.R., Lauretti A., Spieth L., et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 2004, 93(5):582-587.
24. Eicken A., Kolb C., Lange S., et al. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 2006, 107(1):30-35.
25. Thomas S.A., Friedmann E., Gottlieb S.S., et al. Changes in psychosocial distress in heart failure (HF) outpatients with implantable cardioverter defibrillators. Heart Lung 2009, 38:109-120.
26. Pedersen S.S., van den Broek K.C., Theuns D.A., et al. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. Int J Cardiol 2009, [Epub ahead of print].
27. Bostwick J.M., Sola C.L. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am 2007, 30(4):677-688.
28. Sears S.F., Conti J.B. Quality of life and psychological functioning of ICD patients. Heart 2002, 87(5):488-493.
29. Bilge A.K., Ozben B., Demircan S., et al. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006, 29(6):619-626.
30. Crossmann A., Pauli P., Dengler W., et al. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up. Heart Lung 2007, 36(2):87-95.
31. Jacq F., Foulldrin G., Savoure A., et al. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. Gen Hosp Psychiatry 2009, 31(3):266-273.
32. Johansen J.B., Pedersen S.S., Spindler H., et al. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients. Europace 2008, 10(5):545-551.
33. Leosdottir M., Sigurdsson E., Reimarsdottir G., et al. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 2006, 8(3):168-174.
34. Smith G., Dunbar S.B., Valderrama A.L., et al. Gender differences in implantable cardioverter-defibrillator patients at the time of insertion. Prog Cardiovasc Nurs 2006, 21(2):76-82.
35. Spindler H., Johansen J.B., Andersen K., et al. Gender differences in anxiety and concerns about the cardioverter defibrillator. Pacing Clin Electrophysiol 2009, 32(5):614-621.
36. Whang W., Albert C.M., Sears S.F., et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005, 45(7):1090-1095.
37. Seedat S., Scott K.M., Angermeyer M.C., et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry 2009, 66(7):785-795.
38. Luyster F.S., Hughes J.W., Waechter D., et al. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom Med 2006, 68(5):794-800.
39. Dougherty C.M., Hunziker J. Predictors of implantable cardioverter defibrillator shocks during the first year. J Cardiovasc Nurs 2009, 24(1):21-28.
40. Pedersen S.S., van Domburg R.T., Theuns D.A., et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005, 149(4):664-669.
41. van den Broek K.C., Nyklicek I., van der Voort P.H., et al. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J Am Coll Cardiol 2009, 54(6):531-537.
42. Pedersen S.S., Theuns D.A., Erdman R.A., et al. Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol 2008, 31(1):20-27.
43. Dougherty C.M., Thompson E.A., Lewis F.M. Long-term outcomes of a telephone intervention after an ICD. Pacing Clin Electrophysiol 2005, 28(11):1157-1167.
44. Dunbar S.B., Langberg J.J., Reilly C.M., et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009, 32(10):1259-1271.
45. Lewin R.J., Coulton S., Frizelle D.J., et al. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions. Heart 2009, 95(1):63-69.
46. Sears S.F., Sowell L.D., Kuhl E.A., et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol 2007, 30(7):858-864.
47. Edelman S., Lemon J., Kirkness A. Educational intervention for patients with automatic implantable cardioverter defibrillators. Aust J Adv Nurs 2007, 24(3):26-32.
48. O'Hea E., Houseman J., Bedek K., et al. The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF. Heart Fail Rev 2009, 14(1):13-20.
49. Sullivan M.J., Wood L., Terry J., et al. The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J 2009, 157(1):84-90.
50. Kuhl E.A., Sears S.F., Conti J.B. Using computers to improve the psychosocial care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2006, 29(12):1426-1433.
51. Vogt A. Establishing an ICD support group. A framework. Adv Nurse Pract 2006, 14(9):59-60.
52. Dougherty C.M., Lewis F.M., Thompson E.A., et al. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004, 27(12):1594-1602.
53. Dunbar S.B., Funk M., Wood K., et al. Ventricular dysrhythmias: nursing approaches to health outcomes. J Cardiovasc Nurs 2004, 19(5):316-328.
54. Thomas S.A., Chapa D.W., Friedmann E., et al. Depression in patients with heart failure: prevalence, pathophysiological mechanisms, and treatment. Crit Care Nurse 2008, 28(2):40-55.
55. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160(14):2101-2107.
56. Gary R., Lee S.Y. Physical function and quality of life in older women with diastolic heart failure: effects of a progressive walking program on sleep patterns. Prog Cardiovasc Nurs 2007, 22(2):72-80.
57. Luyster F.S., Hughes J.W., Gunstad J. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator. J Cardiovasc Nurs 2009, 24(1):10-17.
58. Redeker N.S. Sleep disturbance in people with heart failure: implications for self-care. J Cardiovasc Nurs 2008, 23(3):231-238.
59. Riegel B., Moser D.K., Anker S.D., et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation 2009, 120(12):1141-1163.
60. van der Wal M.H., Jaarsma T., Moser D.K., et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2006, 27(4):434-440.
61. Watson K., Summers K.M. Depression in patients with heart failure: clinical implications and management. Pharmacotherapy 2009, 29(1):49-63.
62. Lemon J., Edelman S. Psychological adaptation to ICDs and the influence of anxiety sensitivity. Psychol Health Med 2007, 12(2):163-171.
63. Newall E.G., Lever N.A., Prasad S., et al. Psychological implications of ICD implantation in a New Zealand population. Europace 2007, 9(1):20-24.